Resmed vs Intuitive Surgical: Fair Value & Quality
Both stocks run through our valuation models. Here is how Resmed (RMD) and Intuitive Surgical (ISRG) compare, as of Aug 14, 2026.
As of Aug 14, 2026, Fair Value Calculator sees Resmed as the less overvalued of the two: Resmed trades at A$32.03 versus a fair value of A$18.79 (-41%), while Intuitive Surgical trades at $401 versus $150 (-63%).
Resmed
RMD.AU · AUD · Health Care
-41%
upside to fair value
overvalued
PriceA$32.03
Fair ValueA$18.79
Quality77/100
Intuitive Surgical
ISRG · USD · Health Care
-63%
upside to fair value
overvalued
Price$401
Fair Value$150
Quality72/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
ResmedIntuitive Surgical
Valuation
18.5×P/E (TTM)48.3×
5.15×P/S (TTM)13.35×
4.78×P/B7.92×
13.2×EV/EBITDA35.5×
1.16×PEG2.13×
8.1%Dividend yield—
A$2.33Dividend per share—
Profitability
27%Net margin28%
35%Operating margin31%
25%Return on equity17%
15%Return on assets10%
Growth
11%Revenue growth (YoY)23%
12.9%Avg. growth/yr (3Y)17.4%
11.7%Avg. growth/yr (5Y)18.2%
Balance & size
0.11×Debt / equity—
$29BMarket cap$141B
healthyGrowth qualityhealthy
Resmed leads: 8 to 4 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Resmedof which business quality 76 · market factors 40Intuitive Surgicalof which business quality 71 · market factors 25
ProfitabilityMargins and returns on capital today
77
66
Quality GrowthAre margins and returns improving?
64
66
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
38
37
Low VolatilityCalm price path (market factor)
73
39
MomentumPrice trend over the last 3–12 months (market factor)
30
22
52W MomentumDistance to the 52-week high (market factor)
19
13
Net IssuanceBuybacks instead of dilution
82
80
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Resmed
DCF ModelsA$26.63
Earnings-BasedA$13.81
MultiplesA$17.67
Asset-BasedA$2.76
Growth DCFA$22.90
Economic ProfitA$11.78
Growth EarningsA$20.87
23 of 24 models see the stock below the current price.
Intuitive Surgical
DCF Models$219
Earnings-Based$160
Dividend Discount$0.40
Multiples$144
Asset-Based$33.72
Growth DCF$185
Economic Profit$105
Growth Earnings$224
26 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Resmed
Bear A$14.15Fair Value A$18.79Bull A$27.13
A$32.03 = current price (white tick)
Intuitive Surgical
Bear $108Fair Value $150Bull $225
$401 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Resmed · Health Care
Quality score77 · Top 25%
Fair value upside-41% · below median
Intuitive Surgical · Health Care
Quality score72 · Top 25%
Fair value upside-63% · bottom 25%
Bottom line
As of Aug 14, 2026, Fair Value Calculator sees Resmed as the less overvalued of the two: Resmed trades at A$32.03 versus a fair value of A$18.79 (-41%), while Intuitive Surgical trades at $401 versus $150 (-63%).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
